三维腹腔镜与机器人肝切除治疗肝细胞癌的多中心对比研究
该多中心回顾性研究纳入2011至2017年93例肝细胞癌患者,比较三维腹腔镜(3D-LLR,49例)与机器人肝切除(RLR,44例)的手术及长期肿瘤学结局。结果显示两组手术时间、并发症、切缘宽度及3年总生存和无复发生存均无显著差异,提示两种术式可提供相当的短期与长期肿瘤学结局。
要点
- 3D-LLR与RLR在手术时间、总体及严重并发症、切缘宽度上无显著差异。
- 两组3年总生存率(82% vs 91%)和无复发生存率(24% vs 48%)差异均无统计学意义。
- 在肝细胞癌肝切除中,3D-LLR与RLR的短期和长期肿瘤学结局相当。
核心结论
- 3D-LLR与RLR系统可提供相当的 surgical margins,短期和长期肿瘤学结局相似。
研究设计与样本
- 多中心对比研究,回顾性分析2011至2017年93例肝细胞癌患者,其中58例(62%)合并肝硬化。
- 患者接受3D-LLR(49例,53%)或RLR(44例,47%),比较手术时间、并发症、切缘及生存。
主要发现
- 手术时间3D-LLR组269 min vs RLR组252 min(p=0.52)。
- 总体并发症3D-LLR组27% vs RLR组16%(p=0.49),严重并发症4% vs 2%(p=0.77)。
- 切缘宽度3D-LLR组9 mm vs RLR组11 mm(p=0.30)。
- 3年总生存率3D-LLR组82% vs RLR组91%(p=0.16)。
- 3年无复发生存率3D-LLR组24% vs RLR组48%(p=0.18)。
临床怎么用
- 对于适合微创肝切除的肝细胞癌患者,3D-LLR与RLR均可作为可选术式,两者肿瘤学结局相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The recent development of 3D vision in laparoscopic and robotic surgical systems raises the question of whether these two procedures are equivalent. The aim of this study was to evaluate the surgical and long-term oncological outcomes of 3D laparoscopic (3D-LLR) and robotic liver resection (RLR) for hepatocellular carcinoma (HCC). METHODS: The data for operative time, morbidity, margins, and survival were reviewed for 3D-LLR and compared with RLR. RESULTS: From 2011 to 2017, 93 patients with HCC, including 58 (62%) with cirrhosis, underwent 3D-LLR [49 (53%)] or RLR [44 (47%)]. No difference was observed in operative time (269 vs. 252 min; p = 0.52), overall (27% vs. RLR: 16%; p = 0.49) and severe morbidity (4% vs. 2%; p = 0.77) or in the surgical margin width (9 vs. 11 mm; p = 0.30) between the 3D-LLR and RLR groups. The 3-year overall and recurrence-free survival rates after 3D-LLR and RLR were 82% and 24% and 91% (p = 0.16) and 48% (p = 0.18), respectively. CONCLUSIONS: The 3D-LLR and RLR systems provide comparable surgical margins with similar short- and long-term oncological outcomes.
引用
- Lim C, Goumard C, Salloum C, et al. Outcomes after 3D laparoscopic and robotic liver resection for hepatocellular carcinoma: a multicenter comparative study. Surg Endosc. 2020. PMID: 32617657. doi:10.1007/s00464-020-07762-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。